These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24447250)

  • 1. Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
    Soubirou JF; Gault N; Alfaiate T; Lolom I; Tubach F; Andremont A; Lucet JC; Wolff M; Barbier F
    Scand J Infect Dis; 2014 Mar; 46(3):215-20. PubMed ID: 24447250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
    Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
    Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
    Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
    Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenem restriction reduce the incidence of multidrug-resistant Acinetobacter baumannii in ventilator associated pneumonia].
    Xue XS; Wang B; Deng LJ; Kang Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Apr; 21(4):234-6. PubMed ID: 19374793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
    Fihman V; Le Monnier A; Corvec S; Jaureguy F; Tankovic J; Jacquier H; Carbonnelle E; Bille E; Illiaquer M; Cattoir V; Zahar JR
    J Infect; 2012 Apr; 64(4):391-8. PubMed ID: 22245400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.
    Chaari A; Mnif B; Bahloul M; Mahjoubi F; Chtara K; Turki O; Gharbi N; Chelly H; Hammami A; Bouaziz M
    Int J Infect Dis; 2013 Dec; 17(12):e1225-8. PubMed ID: 24094525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changing patterns and the associated factors of microbial pathogens in ventilator-associated pneumonia in a respiratory intensive care unit from 1995 to 2004].
    Yang W; He B; Zhao MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):598-602. PubMed ID: 19080406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.